CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,773 | 9,180 | ||
| 2021-12-01 | Or Yat Sun Sr. VP & CSO | Shares withheld for taxes | −557 | $87.68 | $49K | 337,161 |
| 2021-12-01 | MELLETT PAUL J Treasurer and CFO | Shares withheld for taxes | −557 | $87.68 | $49K | 56,002 |
| 2021-12-01 | Luly Jay R. President and CEO | Shares withheld for taxes | −1,944 | $87.68 | $170K | 700,728 |
| 2021-11-19 | Luu Brendan Sr. VP, Business Dev. | Grant or award | +6,800 | 6,800 | ||
| 2021-11-19 | Luu Brendan Sr. VP, Business Dev. | Grant or award · Stock Option (right to buy) | +28,400 | 28,400 | ||
| 2021-11-19 | Kieffer Tara Lynn Sr. VP, New Product Dev. | Grant or award | +6,800 | 6,800 | ||
| 2021-11-19 | Kieffer Tara Lynn Sr. VP, New Product Dev. | Grant or award · Stock Option (right to buy) | +28,400 | 28,400 | ||
| 2021-11-19 | Gardiner Nathaniel S. Sr. VP & General Counsel | Grant or award | +6,800 | 59,783 | ||
| 2021-11-19 | Gardiner Nathaniel S. Sr. VP & General Counsel | Grant or award · Stock Option (right to buy) | +28,400 | 28,400 | ||
| 2021-11-19 | Adda Nathalie Sr. VP & Chief Medical Officer | Grant or award | +6,800 | 33,744 | ||
| 2021-11-19 | Adda Nathalie Sr. VP & Chief Medical Officer | Grant or award · Stock Option (right to buy) | +28,400 | 28,400 | ||
| 2021-11-19 | Or Yat Sun Sr. VP & CSO | Grant or award | +6,800 | 337,718 | ||
| 2021-11-19 | Or Yat Sun Sr. VP & CSO | Grant or award · Stock Option (right to buy) | +28,400 | 28,400 | ||
| 2021-11-19 | MELLETT PAUL J Treasurer and CFO | Grant or award | +6,800 | 56,559 | ||
| 2021-11-19 | MELLETT PAUL J Treasurer and CFO | Grant or award · Stock Option (right to buy) | +28,400 | 28,400 | ||
| 2021-11-19 | Luly Jay R. President and CEO | Grant or award | +25,700 | 702,672 | ||
| 2021-11-19 | Luly Jay R. President and CEO | Grant or award · Stock Option (right to buy) | +107,800 | 107,800 | ||
| 2021-11-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +9,547 | $48.52 | $463K | 36,491 |
| 2021-11-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −1,952 | $84.31 | $165K | 34,539 |
Page 16 of 19 · 377 trades